These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 10049108)

  • 1. Innovative immunity.
    Beardsley T
    Sci Am; 1999 Feb; 280(2):42, 44. PubMed ID: 10049108
    [No Abstract]   [Full Text] [Related]  

  • 2. Live virus vaccines: something old, something new, something borrowed..
    Dubensky TW; Polo JM; Liu MA
    Nat Med; 1998 Dec; 4(12):1357-8. PubMed ID: 9846565
    [No Abstract]   [Full Text] [Related]  

  • 3. Chimeric Langat/Dengue viruses protect mice from heterologous challenge with the highly virulent strains of tick-borne encephalitis virus.
    Pletnev AG; Karganova GG; Dzhivanyan TI; Lashkevich VA; Bray M
    Virology; 2000 Aug; 274(1):26-31. PubMed ID: 10936085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral and cellular immune response to RNA immunization with flavivirus replicons derived from tick-borne encephalitis virus.
    Aberle JH; Aberle SW; Kofler RM; Mandl CW
    J Virol; 2005 Dec; 79(24):15107-13. PubMed ID: 16306582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of tick-borne encephalitis DNA vaccines in monkeys.
    Schmaljohn C; Custer D; VanderZanden L; Spik K; Rossi C; Bray M
    Virology; 1999 Oct; 263(1):166-74. PubMed ID: 10544091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naked DNA vaccines expressing the prM and E genes of Russian spring summer encephalitis virus and Central European encephalitis virus protect mice from homologous and heterologous challenge.
    Schmaljohn C; Vanderzanden L; Bray M; Custer D; Meyer B; Li D; Rossi C; Fuller D; Fuller J; Haynes J; Huggins J
    J Virol; 1997 Dec; 71(12):9563-9. PubMed ID: 9371620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Needle-free jet injection of DNA and protein vaccine of the far-eastern subtype of tick-borne encephalitis virus induces protective immunity in mice.
    Omori-Urabe Y; Yoshii K; Ikawa-Yoshida A; Kariwa H; Takashima I
    Microbiol Immunol; 2011 Dec; 55(12):893-7. PubMed ID: 22004565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Laboratory methods of controlling immunogenicity of vaccines against tick-borne encephalitis].
    Sokolova ED
    Tr Inst Im Pastera; 1989; 65():90-8. PubMed ID: 2560849
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cleaved vaccine against tick-borne encephalitis].
    Osipova EG; Solianik RG; Fedorov IuV
    Tr Inst Im Pastera; 1989; 65():155-9. PubMed ID: 2629184
    [No Abstract]   [Full Text] [Related]  

  • 10. Recombinant and virion-derived soluble and particulate immunogens for vaccination against tick-borne encephalitis.
    Heinz FX; Allison SL; Stiasny K; Schalich J; Holzmann H; Mandl CW; Kunz C
    Vaccine; 1995 Dec; 13(17):1636-42. PubMed ID: 8719513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel recombinant adenovirus vector expressing a flavivirus non-structural protein protects against lethal flavivirus challenge.
    Jacobs SC
    Clin Sci (Lond); 1993 Aug; 85(2):117-22. PubMed ID: 8403779
    [No Abstract]   [Full Text] [Related]  

  • 12. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes.
    Pletnev AG; Bray M; Hanley KA; Speicher J; Elkins R
    J Virol; 2001 Sep; 75(17):8259-67. PubMed ID: 11483771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The significance of humoral immunity in post-vaccination resistance of mice to tick-borne encephalitis].
    Nikonova AN; Rozhkova LV; Sokolova ED
    Tr Inst Im Pastera; 1989; 65():84-90. PubMed ID: 2560848
    [No Abstract]   [Full Text] [Related]  

  • 14. Tick-borne encephalitis virus: advances in molecular biology and vaccination strategy in the next century.
    Heinz FX
    Zentralbl Bakteriol; 1999 Dec; 289(5-7):506-10. PubMed ID: 10652717
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro-synthesized infectious RNA as an attenuated live vaccine in a flavivirus model.
    Mandl CW; Aberle JH; Aberle SW; Holzmann H; Allison SL; Heinz FX
    Nat Med; 1998 Dec; 4(12):1438-40. PubMed ID: 9846585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation and Characterization of a Chimeric Tick-Borne Encephalitis Virus Attenuated Strain ChinTBEV.
    Wang HJ; Li XF; Qin CF
    Methods Mol Biol; 2016; 1403():285-93. PubMed ID: 27076137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of inbred mice for assessing the neurovirulence of strains of the tick-borne encephalitis virus complex and the immunogenicity of a concentrated tick-borne encephalitis vaccine].
    Kan GA; Borsuk EA; Vorob'eva MS
    Vopr Virusol; 1982; 27(4):461-4. PubMed ID: 7135927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant Semliki Forest virus particles expressing louping ill virus antigens induce a better protective response than plasmid-based DNA vaccines or an inactivated whole particle vaccine.
    Fleeton MN; Liljeström P; Sheahan BJ; Atkins GJ
    J Gen Virol; 2000 Mar; 81(Pt 3):749-58. PubMed ID: 10675413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Field studies of the FSME-immune vaccine against tick encephalitis in Hungary].
    Molnár E; Erdös L; Fornosi F
    Orv Hetil; 1982 Jul; 123(30):1843-8. PubMed ID: 7133680
    [No Abstract]   [Full Text] [Related]  

  • 20. [Quantitative indices of the immune status of persons inoculated with different vaccines against tick-borne encephalitis].
    Bukovskaia SN; Vorob'eva MS; Karpovich LG; Shalamberidze TD
    Vopr Virusol; 1983; 28(4):100-3. PubMed ID: 6636697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.